Teva takes €2bn as euro gold rush endures
Teva Pharmaceuticals priced its largest euro-denominated bond on Tuesday with a dual tranche eight and 12 year which came roughly flat to the dollar equivalent, according to bankers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts